RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION

The present report reviews various aspects of legal regulation, function, guidelines for creation and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug supply policy in theRussian Federation. The following restrictive lists (currently in effec...

Full description

Saved in:
Bibliographic Details
Main Author: M. V. Sura (Author)
Format: Book
Published: IRBIS LLC, 2017-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dd0f2ad857da47e5bfcd11f2f26d3cb0
042 |a dc 
100 1 0 |a M. V. Sura  |e author 
245 0 0 |a RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION 
260 |b IRBIS LLC,   |c 2017-05-01T00:00:00Z. 
500 |a 2070-4909 
500 |a 2070-4933 
500 |a 10.17749/2070-4909.2017.10.1.046-056 
520 |a The present report reviews various aspects of legal regulation, function, guidelines for creation and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug supply policy in theRussian Federation. The following restrictive lists (currently in effect) are carefully analyzed: the list of VED, the list of medications supplied to certain population groups, the list of "7 medical conditions", the minimum assortment, the lists of regional benefits, the lists of medicines to treat rare diseases, in accordance with the list of rare (orphan) diseases, the list of strategically important medications, the list of drugs allowed for tax deduction. 
546 |a RU 
690 |a restrictive lists of drugs 
690 |a legal regulation of drug supply 
690 |a financing of drug supply 
690 |a state guarantees for free public medical care 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Economics as a science 
690 |a HB71-74 
655 7 |a article  |2 local 
786 0 |n Фармакоэкономика, Vol 10, Iss 1, Pp 46-56 (2017) 
787 0 |n https://www.pharmacoeconomics.ru/jour/article/view/182 
787 0 |n https://doaj.org/toc/2070-4909 
787 0 |n https://doaj.org/toc/2070-4933 
856 4 1 |u https://doaj.org/article/dd0f2ad857da47e5bfcd11f2f26d3cb0  |z Connect to this object online.